MMP9 and metabolic dysfunction-associated steatotic liver disease: Nonalcoholic fatty liver disease (NAFLD), often present in the obese patients, is associated with increased serum concentrations of MMP-2, MMP-9, TIMP-1, 2, TGF-beta concentrations.